Goh Hui Shan

Title: Goh Hui Shan: Innovator in Anti-Inflammatory Agents

Introduction

Goh Hui Shan is a notable inventor based in Kuala Lumpur, Malaysia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. His innovative work has led to the creation of compounds that have the potential to improve pain management and treatment options.

Latest Patents

Goh Hui Shan holds a patent for "Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide as anti-inflammatory agents." This patent includes novel compounds that are identified as COX-2 inhibitors, which are useful in treating inflammation and pain. The patent also details a method for synthesizing these compounds, a pharmaceutical composition comprising them, and methods for their application.

Career Highlights

Goh Hui Shan is affiliated with King Fahd University of Petroleum and Minerals, where he continues to engage in research and development. His work focuses on creating effective pharmaceutical solutions that address significant health issues related to inflammation and pain.

Collaborations

Goh has collaborated with esteemed colleagues such as Katharigatta N Venugopala and Pran Kishore Deb. These collaborations have further enhanced the research and development of innovative pharmaceutical compounds.

Conclusion

Goh Hui Shan's contributions to the field of anti-inflammatory agents exemplify the impact of innovative research in pharmaceuticals. His patented work not only showcases his expertise but also holds promise for future advancements in pain management.